أدوية ومنتجات صحية
Aleve 200 mg caplets: Recalled from wholesalers (Distribution Error)
تفاصيل الاستدعاء أدناه منشورة بالإنجليزية كما أصدرتها الحكومة الكندية دون تعديل. لم تنشر الحكومة صوراً لهذا المنتج.
Summary
| Type | Health product recall |
|---|---|
| Product | Aleve |
| Issue | Health products - Other |
| What to do | Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. |
| Brand(s) | Aleve |
| Last updated | 2026-10-15 |
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Aleve |
Aleve |
DIN 02301733 |
Caplets |
220 mg |
NAAEWF2 |
Issue
Customer-returned products were inadvertently reintroduced into saleable inventory and distributed to the wholesale level.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Background
Depth of Recall: Wholesalers
Details
| Original published date | 2026-10-15 |
|---|---|
| Alert / recall type | Health product recall |
| Category | Health products - Drugs |
| Companies | Bayer Inc. 2920 Matheson Blvd. E Mississauga, ON L4W 5R6 |
| Published by | Health Canada |
| Audience | General public Healthcare Industry |
| Recall class | Type III |
| Identification number | RA-82781 |
Source: Government of Canada, Recalls and safety alerts – https://recalls-rappels.canada.ca/en/alert-recall/aleve-200-mg-caplets-recalled-wholesalers-distribution-error